Nu Skin Enterprises, Inc. (NYSE:NUS) Stake Lessened by Quantbot Technologies LP

Quantbot Technologies LP cut its stake in Nu Skin Enterprises, Inc. (NYSE:NUS - Free Report) by 50.8% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund owned 48,992 shares of the company's stock after selling 50,506 shares during the period. Quantbot Technologies LP owned approximately 0.10% of Nu Skin Enterprises worth $338,000 as of its most recent SEC filing.

Other institutional investors have also recently bought and sold shares of the company. Magnetar Financial LLC purchased a new position in shares of Nu Skin Enterprises in the 4th quarter worth $183,000. Signaturefd LLC raised its holdings in shares of Nu Skin Enterprises by 536.8% in the 4th quarter. Signaturefd LLC now owns 8,087 shares of the company's stock worth $56,000 after purchasing an additional 6,817 shares during the period. Corient Private Wealth LLC acquired a new position in shares of Nu Skin Enterprises in the 4th quarter valued at about $128,000. Catalyst Funds Management Pty Ltd grew its holdings in shares of Nu Skin Enterprises by 15.3% during the 4th quarter. Catalyst Funds Management Pty Ltd now owns 39,100 shares of the company's stock worth $269,000 after purchasing an additional 5,200 shares during the period. Finally, Inspire Advisors LLC grew its stake in Nu Skin Enterprises by 49.8% during the fourth quarter. Inspire Advisors LLC now owns 30,586 shares of the company's stock worth $211,000 after buying an additional 10,172 shares during the period. 82.84% of the stock is currently owned by hedge funds and other institutional investors.

Nu Skin Enterprises Stock Down 1.0 %

Shares of NYSE:NUS traded down $0.07 during trading on Wednesday, hitting $7.15. The company's stock had a trading volume of 371,753 shares, compared to its average volume of 823,226. The stock's 50-day moving average price is $7.37 and its two-hundred day moving average price is $7.08. Nu Skin Enterprises, Inc. has a fifty-two week low of $5.95 and a fifty-two week high of $14.00. The company has a market capitalization of $355.52 million, a PE ratio of -2.42 and a beta of 1.06. The company has a debt-to-equity ratio of 0.56, a quick ratio of 1.17 and a current ratio of 1.82.

Remove Ads

Nu Skin Enterprises (NYSE:NUS - Get Free Report) last issued its quarterly earnings results on Thursday, February 13th. The company reported $0.38 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.24 by $0.14. The business had revenue of $445.55 million during the quarter, compared to analyst estimates of $441.10 million. Nu Skin Enterprises had a negative net margin of 8.46% and a positive return on equity of 5.86%. As a group, sell-side analysts expect that Nu Skin Enterprises, Inc. will post 1.05 EPS for the current year.

Nu Skin Enterprises Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, March 5th. Investors of record on Monday, February 24th were paid a dividend of $0.06 per share. This represents a $0.24 annualized dividend and a yield of 3.36%. The ex-dividend date of this dividend was Monday, February 24th. Nu Skin Enterprises's dividend payout ratio (DPR) is presently -8.14%.

Wall Street Analyst Weigh In

A number of brokerages have recently commented on NUS. StockNews.com raised shares of Nu Skin Enterprises from a "hold" rating to a "buy" rating in a research note on Tuesday, February 25th. DA Davidson decreased their price target on Nu Skin Enterprises from $11.00 to $7.00 and set a "neutral" rating for the company in a report on Friday, December 20th.

Nu Skin Enterprises Profile

Nu Skin Enterprises, Inc, together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa and ageLOC LumiSpa iO; and nutricentials skin care products.